Logo image of BMI

BADGER METER INC (BMI) Stock Fundamental Analysis

NYSE:BMI - US0565251081 - Common Stock

185.07 USD
-4.22 (-2.23%)
Last: 8/25/2025, 8:06:43 PM
186 USD
+0.93 (+0.5%)
After Hours: 8/25/2025, 8:06:43 PM
Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to BMI. BMI was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. BMI scores excellent points on both the profitability and health parts. This is a solid base for a good stock. While showing a medium growth rate, BMI is valued expensive at the moment. This makes BMI very considerable for quality investing!


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

BMI had positive earnings in the past year.
In the past year BMI had a positive cash flow from operations.
In the past 5 years BMI has always been profitable.
In the past 5 years BMI always reported a positive cash flow from operatings.
BMI Yearly Net Income VS EBIT VS OCF VS FCFBMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

BMI's Return On Assets of 14.50% is amongst the best of the industry. BMI outperforms 93.55% of its industry peers.
Looking at the Return On Equity, with a value of 20.03%, BMI belongs to the top of the industry, outperforming 89.52% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 16.48%, BMI belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BMI is significantly above the industry average of 9.67%.
The last Return On Invested Capital (16.48%) for BMI is above the 3 year average (15.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 14.5%
ROE 20.03%
ROIC 16.48%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
BMI Yearly ROA, ROE, ROICBMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

The Profit Margin of BMI (15.53%) is better than 94.35% of its industry peers.
In the last couple of years the Profit Margin of BMI has grown nicely.
The Operating Margin of BMI (19.93%) is better than 98.39% of its industry peers.
In the last couple of years the Operating Margin of BMI has grown nicely.
BMI has a Gross Margin of 41.18%. This is in the better half of the industry: BMI outperforms 70.16% of its industry peers.
BMI's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 19.93%
PM (TTM) 15.53%
GM 41.18%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
BMI Yearly Profit, Operating, Gross MarginsBMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

8

2. Health

2.1 Basic Checks

BMI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
BMI has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BMI has more shares outstanding
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BMI Yearly Shares OutstandingBMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BMI Yearly Total Debt VS Total AssetsBMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

BMI has an Altman-Z score of 15.48. This indicates that BMI is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BMI (15.48) is better than 95.16% of its industry peers.
BMI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 15.48
ROIC/WACC1.73
WACC9.51%
BMI Yearly LT Debt VS Equity VS FCFBMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

BMI has a Current Ratio of 3.23. This indicates that BMI is financially healthy and has no problem in meeting its short term obligations.
BMI has a Current ratio of 3.23. This is in the better half of the industry: BMI outperforms 69.35% of its industry peers.
A Quick Ratio of 2.17 indicates that BMI has no problem at all paying its short term obligations.
BMI's Quick ratio of 2.17 is fine compared to the rest of the industry. BMI outperforms 64.52% of its industry peers.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 2.17
BMI Yearly Current Assets VS Current LiabilitesBMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

6

3. Growth

3.1 Past

BMI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.84%, which is quite good.
The Earnings Per Share has been growing by 21.16% on average over the past years. This is a very strong growth
BMI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.82%.
Measured over the past years, BMI shows a quite strong growth in Revenue. The Revenue has been growing by 14.25% on average per year.
EPS 1Y (TTM)19.84%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%4.46%
Revenue 1Y (TTM)11.82%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%9.89%

3.2 Future

BMI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.18% yearly.
The Revenue is expected to grow by 9.30% on average over the next years. This is quite good.
EPS Next Y14.48%
EPS Next 2Y13.21%
EPS Next 3Y9.86%
EPS Next 5Y12.18%
Revenue Next Year12.41%
Revenue Next 2Y10.35%
Revenue Next 3Y8.27%
Revenue Next 5Y9.3%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BMI Yearly Revenue VS EstimatesBMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
BMI Yearly EPS VS EstimatesBMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 40.32, the valuation of BMI can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as BMI.
When comparing the Price/Earnings ratio of BMI to the average of the S&P500 Index (27.03), we can say BMI is valued slightly more expensively.
The Price/Forward Earnings ratio is 34.14, which means the current valuation is very expensive for BMI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BMI is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, BMI is valued quite expensively.
Industry RankSector Rank
PE 40.32
Fwd PE 34.14
BMI Price Earnings VS Forward Price EarningsBMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

BMI's Enterprise Value to EBITDA ratio is in line with the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BMI indicates a somewhat cheap valuation: BMI is cheaper than 69.35% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.07
EV/EBITDA 25.51
BMI Per share dataBMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BMI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.79
PEG (5Y)1.91
EPS Next 2Y13.21%
EPS Next 3Y9.86%

6

5. Dividend

5.1 Amount

BMI has a yearly dividend return of 0.87%, which is pretty low.
In the last 3 months the price of BMI has falen by -25.44%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
Compared to an average industry Dividend Yield of 1.61, BMI pays a better dividend. On top of this BMI pays more dividend than 85.48% of the companies listed in the same industry.
With a Dividend Yield of 0.87, BMI pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

The dividend of BMI is nicely growing with an annual growth rate of 13.80%!
BMI has been paying a dividend for at least 10 years, so it has a reliable track record.
BMI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)13.8%
Div Incr Years18
Div Non Decr Years18
BMI Yearly Dividends per shareBMI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

BMI pays out 29.46% of its income as dividend. This is a sustainable payout ratio.
BMI's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.46%
EPS Next 2Y13.21%
EPS Next 3Y9.86%
BMI Yearly Income VS Free CF VS DividendBMI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
BMI Dividend Payout.BMI Dividend Payout, showing the Payout Ratio.BMI Dividend Payout.PayoutRetained Earnings

BADGER METER INC

NYSE:BMI (8/25/2025, 8:06:43 PM)

After market: 186 +0.93 (+0.5%)

185.07

-4.22 (-2.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-15 2025-10-15/bmo
Inst Owners100.18%
Inst Owner Change-0.78%
Ins Owners0.51%
Ins Owner Change-2.92%
Market Cap5.45B
Analysts72.86
Price Target238.7 (28.98%)
Short Float %6.48%
Short Ratio5.78
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend1.22
Dividend Growth(5Y)13.8%
DP29.46%
Div Incr Years18
Div Non Decr Years18
Ex-Date08-22 2025-08-22 (0.4)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.16%
Min EPS beat(2)-7.6%
Max EPS beat(2)21.92%
EPS beat(4)1
Avg EPS beat(4)1.17%
Min EPS beat(4)-7.6%
Max EPS beat(4)21.92%
EPS beat(8)5
Avg EPS beat(8)5.19%
EPS beat(12)8
Avg EPS beat(12)6.49%
EPS beat(16)11
Avg EPS beat(16)7.17%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.51%
Max Revenue beat(2)-0.39%
Revenue beat(4)1
Avg Revenue beat(4)-0.79%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)0.46%
Revenue beat(8)4
Avg Revenue beat(8)1.37%
Revenue beat(12)8
Avg Revenue beat(12)3.2%
Revenue beat(16)11
Avg Revenue beat(16)2.85%
PT rev (1m)0.29%
PT rev (3m)5.07%
EPS NQ rev (1m)-2.24%
EPS NQ rev (3m)-5.81%
EPS NY rev (1m)-3.27%
EPS NY rev (3m)-1.48%
Revenue NQ rev (1m)-0.75%
Revenue NQ rev (3m)-1.53%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE 40.32
Fwd PE 34.14
P/S 6.24
P/FCF 34.07
P/OCF 31.21
P/B 8.05
P/tB 17.27
EV/EBITDA 25.51
EPS(TTM)4.59
EY2.48%
EPS(NY)5.42
Fwd EY2.93%
FCF(TTM)5.43
FCFY2.93%
OCF(TTM)5.93
OCFY3.2%
SpS29.65
BVpS22.99
TBVpS10.72
PEG (NY)2.79
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 14.5%
ROE 20.03%
ROCE 21.83%
ROIC 16.48%
ROICexc 20.78%
ROICexgc 48.56%
OM 19.93%
PM (TTM) 15.53%
GM 41.18%
FCFM 18.32%
ROA(3y)13.08%
ROA(5y)12.25%
ROE(3y)17.86%
ROE(5y)16.46%
ROIC(3y)15.23%
ROIC(5y)14.23%
ROICexc(3y)23.61%
ROICexc(5y)20.43%
ROICexgc(3y)41.01%
ROICexgc(5y)36.17%
ROCE(3y)20.17%
ROCE(5y)18.85%
ROICexcg growth 3Y15.78%
ROICexcg growth 5Y16.08%
ROICexc growth 3Y21.65%
ROICexc growth 5Y15.12%
OM growth 3Y7.03%
OM growth 5Y5.49%
PM growth 3Y7.84%
PM growth 5Y6.34%
GM growth 3Y-0.7%
GM growth 5Y0.68%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 44.34%
Cap/Sales 1.68%
Interest Coverage 250
Cash Conversion 84.31%
Profit Quality 117.92%
Current Ratio 3.23
Quick Ratio 2.17
Altman-Z 15.48
F-Score6
WACC9.51%
ROIC/WACC1.73
Cap/Depr(3y)34.99%
Cap/Depr(5y)33.03%
Cap/Sales(3y)1.43%
Cap/Sales(5y)1.55%
Profit Quality(3y)111.64%
Profit Quality(5y)126.18%
High Growth Momentum
Growth
EPS 1Y (TTM)19.84%
EPS 3Y26.69%
EPS 5Y21.16%
EPS Q2Q%4.46%
EPS Next Y14.48%
EPS Next 2Y13.21%
EPS Next 3Y9.86%
EPS Next 5Y12.18%
Revenue 1Y (TTM)11.82%
Revenue growth 3Y17.83%
Revenue growth 5Y14.25%
Sales Q2Q%9.89%
Revenue Next Year12.41%
Revenue Next 2Y10.35%
Revenue Next 3Y8.27%
Revenue Next 5Y9.3%
EBIT growth 1Y22.98%
EBIT growth 3Y26.12%
EBIT growth 5Y20.53%
EBIT Next Year38.5%
EBIT Next 3Y16.14%
EBIT Next 5Y15.62%
FCF growth 1Y90.04%
FCF growth 3Y20.76%
FCF growth 5Y14.2%
OCF growth 1Y85.38%
OCF growth 3Y21%
OCF growth 5Y13.95%